$CMXC Cell MedX Corp. (OTCQB: CMXC), ("Cell MedX"
Post# of 145157
(Total Views: 61)
Posted On: 05/04/2017 1:47:32 PM
$CMXC Cell MedX Corp. (OTCQB: CMXC), ("Cell MedX" or the "Company"
, is pleased to announce that the Company's Canadian subsidiary has entered into a production agreement with an ISO 9001 certified manufacturing facility in Coquitlam, BC, and selected North American suppliers for sourcing essential components for its eBalance Pro device.
The move is intended to allow the Company to facilitate its planned distribution under the current registration with the U.S. Food and Drug Administration while ensuring lower production costs and greater control of the manufacturing and distribution process. Furthermore, it will assist the Company with setting up its standard operating procedures under ISO 13485-2016, a requirement by Health Canada to register the Company's eBalance Pro device as Class II medical device.
Mr. McEnulty, the Company's CEO, stated: "Our team is very excited to continue moving ahead with our strategic plan. The new relationships that we secured with both the manufacturing facility as well as with our new suppliers is the next essential step to bring our eBalance Pro device to market."
, is pleased to announce that the Company's Canadian subsidiary has entered into a production agreement with an ISO 9001 certified manufacturing facility in Coquitlam, BC, and selected North American suppliers for sourcing essential components for its eBalance Pro device. The move is intended to allow the Company to facilitate its planned distribution under the current registration with the U.S. Food and Drug Administration while ensuring lower production costs and greater control of the manufacturing and distribution process. Furthermore, it will assist the Company with setting up its standard operating procedures under ISO 13485-2016, a requirement by Health Canada to register the Company's eBalance Pro device as Class II medical device.
Mr. McEnulty, the Company's CEO, stated: "Our team is very excited to continue moving ahead with our strategic plan. The new relationships that we secured with both the manufacturing facility as well as with our new suppliers is the next essential step to bring our eBalance Pro device to market."
(0)
(0)